Related references
Note: Only part of the references are listed.Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)
James L. Sherwood et al.
PLOS ONE (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
Tony Mok et al.
CLINICAL CANCER RESEARCH (2015)
Circulating free DNA concentration is an independent prognostic biomarker in lung cancer
Claire Tissot et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing
Suqin Liu et al.
HUMAN GENOMICS (2015)
Gefitinib Treatment in EGFR Mutated Caucasian NSCLC Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
Jean-Yves Douillard et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Frequent Mutations in EGFR, KRAS and TP53 Genes in Human Lung Cancer Tumors Detected by Ion Torrent DNA Sequencing
Xin Cai et al.
PLOS ONE (2014)
PIK3CA and TP53 Gene Mutations in Human Breast Cancer Tumors Frequently Detected by Ion Torrent DNA Sequencing
Xusheng Bai et al.
PLOS ONE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors
Zhi Xu et al.
SCIENTIFIC REPORTS (2014)
Cancer heterogeneity: implications for targeted therapeutics
R. Fisher et al.
BRITISH JOURNAL OF CANCER (2013)
Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
Hye-Ryoun Kim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
PET/CT Imaging in Oncology: Exceptions That Prove the Rule
M. Casali et al.
CASE REPORTS IN ONCOLOGICAL MEDICINE (2013)
Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
Azeet Narayan et al.
CANCER RESEARCH (2012)
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Luis A. Diaz et al.
NATURE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
Kazuya Taniguchi et al.
CLINICAL CANCER RESEARCH (2011)
Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer
Rafael Sirera et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Plasma DNA Quantification in Lung Cancer Computed Tomography Screening Five-Year Results of a Prospective Study
Gabriella Sozzi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients
M Beau-Faller et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Quantification of free circulating DNA as a diagnostic marker in lung cancer
G Sozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
